111, Inc. Sponsored ADR (NASDAQ:YI) Sees Significant Growth in Short Interest

111, Inc. Sponsored ADR (NASDAQ:YI – Get Free Report) saw a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 13,122 shares, a growth of 204.2% from the October 15th total of 4,313 shares. Based on an average trading volume of 18,014 shares, the short-interest ratio is presently 0.7 days. Currently, 0.3% of the shares of the stock are short sold.

Analysts Set New Price Targets

Separately, Weiss Ratings raised 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, November 2nd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat, the company has an average rating of “Sell”.

View Our Latest Stock Analysis on 111

111 Price Performance

NASDAQ:YI opened at $2.85 on Friday. The firm’s 50 day simple moving average is $3.23 and its 200 day simple moving average is $4.94. 111 has a one year low of $2.48 and a one year high of $11.17. The company has a market cap of $25.05 million, a PE ratio of -1.78 and a beta of 0.78.

111 (NASDAQ:YI – Get Free Report) last posted its earnings results on Friday, September 18th. The company reported ($0.60) earnings per share for the quarter. The business had revenue of $338.55 million for the quarter.

111 Company Profile

(Get Free Report)

111, Inc. is a China-based healthcare technology company that operates an online platform connecting consumers, pharmaceutical manufacturers, distributors and healthcare providers. The company focuses on improving access to medicines and health-related products through digital retail and supply-chain services. Its business includes online sales of prescription and over-the-counter medicines, nutritional products, medical devices and other healthcare products. Through its technology platform, 111 also provides services intended to support pharmaceutical companies and pharmacies with product distribution, marketing, data and fulfillment.

Featured Stories

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.